Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?
Abstract
Gangil J, Thunga G, Nagaich R
Today many countries either fail to provide protection or the protection that they provide falls below the levels required by Trade Related Aspects of Intellectual Property Rights (TRIPS). Data exclusivity is one of the most interesting issues in the current discussion on pharmaceutical intellectual property policy making on the global pitch. Data exclusivity, also known as marketing exclusivity, refers to a practice whereby, for a fixed period of time, drug regulatory authorities do not allow the registration files of a pioneer company to be used to register a therapeutically equivalent generic version of that medicine. Only with a clear understanding of the data exclusivity issue and a concerted effort by governments and industries, such as the pharmaceutical industry, that are required to provide registration data to governments have the assurances that their extensive efforts to research, develop, and bring new, innovative products to market will not be subject to unfair business use. Data exclusivity also plays a key role in the development and marketing of new biologics.
| How to Cite this Article |
| Pubmed Style Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. 2010; 1(2): 190-193. doi:10.4103/0975-8453.75088 Web Style Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. http://www.sysrevpharm.org/?mno=302644624 [Access: March 28, 2021]. doi:10.4103/0975-8453.75088 AMA (American Medical Association) Style Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. 2010; 1(2): 190-193. doi:10.4103/0975-8453.75088 Vancouver/ICMJE Style Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. (2010), [cited March 28, 2021]; 1(2): 190-193. doi:10.4103/0975-8453.75088 Harvard Style Gangil J, Thunga G, Nagaich R (2010) Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP, 1 (2), 190-193. doi:10.4103/0975-8453.75088 Turabian Style Gangil J, Thunga G, Nagaich R. 2010. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. Systematic Reviews in Pharmacy, 1 (2), 190-193. doi:10.4103/0975-8453.75088 Chicago Style Gangil J, Thunga G, Nagaich R. "Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?." Systematic Reviews in Pharmacy 1 (2010), 190-193. doi:10.4103/0975-8453.75088 MLA (The Modern Language Association) Style Gangil J, Thunga G, Nagaich R. "Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?." Systematic Reviews in Pharmacy 1.2 (2010), 190-193. Print. doi:10.4103/0975-8453.75088 APA (American Psychological Association) Style Gangil J, Thunga G, Nagaich R (2010) Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. Systematic Reviews in Pharmacy, 1 (2), 190-193. doi:10.4103/0975-8453.75088< |
Abstract
PDF
How to cite this article
Related Records